KA
Kiran Asarpota at ASLAN Pharmaceuticals (ROCO: 6497)
Developer of oncology focused drugs and therapies
ContactFirm
ASLAN Pharmaceuticals (ROCO: 6497)
Location
Global
Investment Stage
Growth
Geographic Focus
Global
About Kiran Asarpota
Enriching content...
Similar Investors in Global
Contact ASLAN Pharmaceuticals (ROCO: 6497)
Get in touch for investment criteria and partnership opportunities.
Contact